University of Colorado researchers will scan Venus during a spacecraft flyby this week using an $8.7 million instrument they designed and built for NASA's MESSENGER Mission, launched in 2004 and speeding toward Mercury.

Built by CU-Boulder's Laboratory for Atmospheric and Space Physics, the instrument will make measurements of the thick clouds and shrouded surface of Venus during the June 5th flyby, said LASP Senior Research Associate William McClintock, a mission co-investigator who led the CU-Boulder instrument development team.

A team of researchers from Arizona State University, Purdue University and the Norwegian University of Life Sciences has discovered evidence that honeybees have adopted a phylogenetically old molecular cascade – TOR (target of rapamycin), linked to nutrient and energy sensing – and put it to use in caste development.

To learn a language is to learn a set of all-purpose rules that can be used in an infinite number of ways. A new study shows that by the age of seven months, human infants are on the lookout for abstract rules – and that they know the best place to look for such abstractions is in human speech.

Carbon monoxide (CO) poisoning kills over 200 people every year in the United States. Although inexpensive CO detectors have been available since 1989, their use in hotels, motels and resorts is not widespread. In fact, while every guest room in the U.S. must contain a smoke detector, there is no federal mandate for CO detectors.

While recent advances in neurosurgery have made it possible to precisely target areas in the brain with minimum invasiveness -- using a small hole to insert a probe, needle or catheter -- there remains a disadvantage. The small size of the openings reduces or eliminates direct site visibility and requires greater dexterity, stability and precision by the surgeon.

A groundbreaking surgical therapy capable of stabilising and restoring vision in the vast majority of patients who currently suffer blindness through Age-Related Macular Degeneration (AMD) is to be taken to clinical trial by scientists and clinicians at the UCL Institute of Ophthalmology, Moorfields Eye Hospital and the University of Sheffield.

The therapy, using cells derived from human embryonic stem cells to replace the faulty retinal cells that cause AMD, will be developed by the London Project to Cure AMD, a collaborative project launched today bringing together some of the leading specialists in the field.